![JFMK | Free Full-Text | Diabetes Type 2 and Physical Activity Program: Potential Application of Risk-Engine UKPDS Score in Out-Patient Context JFMK | Free Full-Text | Diabetes Type 2 and Physical Activity Program: Potential Application of Risk-Engine UKPDS Score in Out-Patient Context](https://pub.mdpi-res.com/jfmk/jfmk-03-00003/article_deploy/html/images/jfmk-03-00003-g001-550.jpg?1569752259)
JFMK | Free Full-Text | Diabetes Type 2 and Physical Activity Program: Potential Application of Risk-Engine UKPDS Score in Out-Patient Context
![Coronary heart disease risk assessment in diabetes mellitus: comparison of UKPDS risk engine with Framingham risk assessment function and its clinical implications - Song - 2004 - Diabetic Medicine - Wiley Online Library Coronary heart disease risk assessment in diabetes mellitus: comparison of UKPDS risk engine with Framingham risk assessment function and its clinical implications - Song - 2004 - Diabetic Medicine - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/1252bc08-e828-4181-a6f9-820640a27636/dme_1116_f2.gif)
Coronary heart disease risk assessment in diabetes mellitus: comparison of UKPDS risk engine with Framingham risk assessment function and its clinical implications - Song - 2004 - Diabetic Medicine - Wiley Online Library
![GPs' familiarity with and use of cardiovascular clinical prediction rules: a UK survey study | BJGP Open GPs' familiarity with and use of cardiovascular clinical prediction rules: a UK survey study | BJGP Open](https://bjgpopen.org/content/bjgpoa/4/5/bjgpopen20X101081/F1.large.jpg)
GPs' familiarity with and use of cardiovascular clinical prediction rules: a UK survey study | BJGP Open
![Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33) - The Lancet Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33) - The Lancet](https://www.thelancet.com/cms/attachment/d314687b-81bc-4d52-9ffc-6be0db0ff818/gr1.jpg)
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33) - The Lancet
![PDF) Comparison of cardiovascular risk calculators in patients with diabetes | Vanessa Moraes Bezerra - Academia.edu PDF) Comparison of cardiovascular risk calculators in patients with diabetes | Vanessa Moraes Bezerra - Academia.edu](https://0.academia-photos.com/attachment_thumbnails/69112897/mini_magick20210906-9854-1qd6uob.png?1630931563)
PDF) Comparison of cardiovascular risk calculators in patients with diabetes | Vanessa Moraes Bezerra - Academia.edu
![Evaluation of risk equations for prediction of short-term coronary heart disease events in patients with long-standing type 2 diabetes: the Translating Research into Action for Diabetes (TRIAD) study | BMC Endocrine Disorders Evaluation of risk equations for prediction of short-term coronary heart disease events in patients with long-standing type 2 diabetes: the Translating Research into Action for Diabetes (TRIAD) study | BMC Endocrine Disorders](https://media.springernature.com/m685/springer-static/image/art%3A10.1186%2F1472-6823-12-12/MediaObjects/12902_2012_Article_133_Fig1_HTML.jpg)
Evaluation of risk equations for prediction of short-term coronary heart disease events in patients with long-standing type 2 diabetes: the Translating Research into Action for Diabetes (TRIAD) study | BMC Endocrine Disorders
HOMA-beta in the UKPDS and ADOPT. Is the natural history of type 2 diabetes characterised by a progressive and inexorable loss of insulin secretory function? Maybe? Maybe not? - Gerald M. Reaven,
![Hypertension Dr. Elizabeth Swiggum, Cardiologist Dr. Anthony Nielsen, Medical Lead CVRR. - ppt download Hypertension Dr. Elizabeth Swiggum, Cardiologist Dr. Anthony Nielsen, Medical Lead CVRR. - ppt download](https://images.slideplayer.com/35/10513301/slides/slide_18.jpg)
Hypertension Dr. Elizabeth Swiggum, Cardiologist Dr. Anthony Nielsen, Medical Lead CVRR. - ppt download
View of Early impact of liraglutide in routine clinical use (ABCD nationwide liraglutide audit) on cardiovascular risk (UKPDS risk engine) | British Journal of Diabetes
![Patient reactions to a web-based cardiovascular risk calculator in type 2 diabetes: a qualitative study in primary care | British Journal of General Practice Patient reactions to a web-based cardiovascular risk calculator in type 2 diabetes: a qualitative study in primary care | British Journal of General Practice](https://bjgp.org/content/bjgp/65/632/e152/F1.large.jpg)